(Q53109746)
Statements
Unconventional end points in cardiovascular clinical trials: should we be moving away from morbidity and mortality? (English)
Faiez Zannad
1 reference
Jay Cohn
Jacobus Lubsen
Jeffrey S Borer
Michael Perelman
25 December 2008
15
3
199-205